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ABSTRACT
Prostate cancer is the most common cancer in men in the UK accounting for 25% of all new cases of cancer.
It is predicted to become the most common cancer overall by 2030. A national survey of the specialist nursing
workforce caring for men with prostate cancer was completed across the four countries of the UK during June
and July 2014. In total 302 specialist nurses completed the survey and data from 285 was used in the analysis.
This is the biggest whole population survey of this workforce in recent years. The most common job title was
clinical nurse specialist (185) and the most common band was agenda for change band 7 (174). However
in Scotland 50% of the respondents stated that they were paid on band 6. Over half the group (158) had
worked in prostate cancer care for more than 10 years. Few (48) had come into specialist posts from a specific
specialist nurse development role. There is wide geographic variation in the provision of specialist nursing for
men with prostate cancer. This is reflected in available hours and caseload sizes. The respondents reported
frozen and vacant posts across the UK. This equated to 58·3 full time equivalents. The work of specialist nurses
caring for men with prostate cancer is clinically complex and appears to cover most key times in the cancer
journey. However workload appears to be limiting the care that the nurses are able to provide with over half the
respondents (163) saying that they left work undone for patients.
Key words: Clinical nurse specialist • Nursing cancer • Prostate cancer • Workforce
RATIONALE/BACKGROUND FOR THE
STUDY
Prostate cancer is the most common cancer in men in
the UK accounting for 25% of all new cases of cancer
and it is predicted to become the most common cancer
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overall by 2030 (Mistry et al., 2011). Over 41 000 men
were diagnosed with prostate cancer (114/d) in the UK
in 2011 and over a quarter of a million men are liv-
ing with and after prostate cancer (Maddams et al.,
2014). Over the last 40 years prostate cancer incidence
rates in Great Britain have more than tripled (Cancer
Research UK, 2014a). Almost three-quarters (74%) of
prostate cancer cases are diagnosed in men aged 65
years and older (Cancer Research UK, 2014b) and it
is the second most common cause of cancer death in
men, after lung cancer, causing over 10,000 deaths
in the UK in 2012 (Cancer Research UK, 2014c). The
National Cancer Patient Experience Survey (NCPES)
in England has showed that patients with cancer who
have access to a clinical nurse specialist (CNS), gen-
erally report better experiences and understanding of
the disease (Department of Health, 2010, 2012; NHS
England, 2013, 2014).
Recent empirical and anecdotal evidence has
highlighted issues about the current urology nursing
workforce and its ability to meet the future needs of
the increasing number of men suffering from prostate
cancer and prostate disease. Specialist cancer nursing
is widely recognized as an essential part of cancer
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care, providing technical expertise, meeting infor-
mation needs and offering emotional support and
coordination (Department of Health, 2007). Clinical
nurse specialists (CNSs) play a key role in the prostate
cancer patient pathway but there is concern that spe-
cialist nursing provision is insufficient, inconsistent
and inequitable (Trevatt and Leary, 2010), and will
be unable to meet increasing demand for specialist
cancer nursing care across the UK. In addition there
are few opportunities for progression or systems lead-
ership with only three uro-oncology consultant nurse
posts currently in England (Macmillan Cancer Support,
2014). These workforce challenges must be seen in
the wider context of NHS reforms, in particular with
respect to tightened budgets and a move to provide
more care in the community/primary care settings,
rather than in secondary care.
Specialist nurse roles have been an informal part of
the cancer nursing workforce for many years, with the
first formal recognition provided in the Calman-Hine
report (Department of Health, 1995). A number of
drivers have influenced the number and extent of CNS
role development over the past two decades including
reduced availability of junior doctors, the EU working
time directive and the introduction of waiting time tar-
gets (Department of Health, 1999, 2000). However, in
contrast to these reactive drivers for role development,
cancer nursing was identified as a key component of
the English NHS Cancer Plan in 2000. A decade on, the
role of the CNS in oncology was reported as ill-defined,
with a wide variation in job titles, responsibilities, train-
ing and expected competencies (Farrell et al., 2011);
findings from a study conducted across four NHS
Trusts in the UK with uro-oncology nurses working in
prostate cancer showed similar wide variation in qual-
ifications, experience and services provided (Ream
et al., 2009). This is not unique to the UK, with similar
problems articulated in Australia (Lowe et al., 2012).
Within cancer policy, the value and significance of
the post appears to have grown exponentially, from lim-
ited referencing in early policy documents (DH, 1995,
2000) to more detailed recommendations clearly artic-
ulating the role, value and worth, together with chal-
lenges variability and access to CNS services. Later
cancer policy (DH, 2007, 2011) set out clear messages
to providers and commissioners about provision and
CNS numbers. These documents were further com-
plimented by national reports which defined the eco-
nomic value of the specialist role in terms of qual-
ity improvement, increased productivity and efficiency
(NCAT, 2010, 2011).
The value and importance of the role was fur-
ther articulated in the findings of the English NCPES
(DH, 2010, 2012; NHS England, 2013, 2014), which
demonstrated a clear relationship between positive
patient experience and CNS access.
The latest evidence suggests that patient contact
with a cancer CNS has increased from 84% (Depart-
ment of Health, 2010) to 89% (NHS England, 2014).
Not all men with prostate cancer are receiving
access to a named specialist nurse. Findings from the
NCPES in England in 2014 identified that 88% of the
6288 prostate cancer respondents had been given the
name of a CNS who would be in charge of their care,
with the poorest trust reporting only 32% (NHS Eng-
land, 2014). According to the National Prostate Cancer
Audit, almost all (95%) of the 142 NHS trusts in Eng-
land provide access to a urological CNS and 67 (47%)
provide access to an oncological CNS. The National
Cancer Director in England reported that the care pro-
vided by nurse specialists was ‘one of the most positive
aspects of the survey’ (Richards, 2010). The Welsh
Cancer Patient Experience Survey reported that 54%
of men in Wales with prostate cancer were given the
name and contact details of their key worker (Welsh
Government, 2014). In Scotland, 76% of prostate can-
cer patients were given the name of a specialist nurse
(Prostate Cancer UK, 2013). Taken as a whole, these
challenges point to the need to map uro-oncology CNS
roles, in order to inform future workforce planning.
RESEARCH QUESTIONS OR AIMS OF
PROJECT
The aim of this project was to gain an understanding
of the current nursing workforce providing care for
men with prostate cancer across all four countries of
the UK. This included demographic information and
areas of need such as education and development
and workload.
Sample
This is a whole population sample study. The available
population was determined by the British Association
of Urological Nurses (BAUN) membership and the
previous national census (Macmillan Cancer Support,
2014).
Data collection methods
A 24-item survey questionnaire was developed for this
population by consensus using clinical and academic
experts. This was transferred to an online survey tool
(Survey Monkey secure account). Ethical approval was
sought and granted by Plymouth University ethics com-
mittee. The survey was developed during April and
May 2014 and distributed through formal and infor-
mal networks, mailing lists, the nursing press, tar-
geted interest groups such as BAUN, NHS Contact,
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Country
England
Scotland
Wales
Northern Ireland
Figure 1 Response by country.
Length of service
Less than a year
1-3 years
4-6 years
7-10 years
Over 10 years
Would rather 
not say
Figure 2 Workforce by length of service.
Help, Advice and Information Network (CHAIN), the UK
Oncology Nursing Society (UKONS) and social media
(Twitter) during June and July of 2014.
Data analysis
Data was exported into Excel and modelled using a
descriptive statistics approach. Participants in the sur-
vey were also invited to provide additional information
on areas such as education, workload or any other
issues they felt relevant. These free text comments
were analysed using thematic content analysis. Each
comment was coded and themes emerged from the
codes. Data excerpts are included below alongside
quantitative findings, to provide context. Excerpts are
annotated according to job title and pay band (e.g.
CNS/band 6).
Findings/Results
There were 302 respondents in total. After cleaning,
the data from 285 respondents was used. The other
records were removed as they were incomplete sub-
missions or submissions from countries outside of the
UK. Data was collected from across the UK however it
should be noted that the four countries of the UK have
different cancer policies and systems to deliver cancer
care. In addition, the size of the workforce varies signifi-
cantly; this is reflected in the number of responses from
each country. Wales and Northern Ireland had the low-
est number of responses (Figure 1). According to the
survey results, the number of nurses providing special-
ist care to men with prostate cancer across the UK is
shown in Figure 1.
Demographics
The majority of the group is at band 7 (n=174, 61%).
However there are 66 (23%) band 6 posts. In Scot-
land, band 6 is the most frequently declared grad-
ing – representing 50% of the declared posts. Just
over half (n=158, 55%) of the 285 respondents said
they had been in post for 10 years or more Figure 2.
© 2015 John Wiley & Sons Ltd. and BAUN 3
Prostate specialist nurse survey
Caseload
Fewer than 100
patients
101-200
patients
201-300
patients
301-400
patients
401-500
patients
501-600
patients
Greater than 
600 patients
Unknown
Figure 3 Caseload.
Area of practice
Benign
Chemo/day care
Continence
Research/clinical
trials
Surgery (including 
day surgery)
Uro-oncology (includes
prostate,bladder, 
testicular etc.)
Figure 4 The declared main area of practice.
Only in Scotland were there more than 50% of nurses
who had been in post less than 10 years. Caseloads
of 201–300 patients and greater than 600 patients
were the most commonly recorded by respondents
(Figure 3). In line with the UK specialist cancer nurs-
ing census (Macmillan Cancer Support, 2014) the most
common job title was CNS with a count of 185. It is
interesting to note the presence of one band 5 and
four band 6 nurse practitioners. This role is usually
associated with advanced practice roles at band 7
or 8. Respondents were asked to declare their main
area of practice – the setting in which they spent over
50% of their time. A total of 285 responded to this
question. The majority worked in a uro-oncology set-
ting (Figure 4) but there is an interesting mix of those
working in benign and continence settings. Unlike other
cancer sites, which have disease-specific specialist
nurses, prostate cancer care is delivered by a range
of practitioner groups. Detailed findings are presented
below and, where appropriate, set in the content of the
national census (Macmillan Cancer Support, 2014).
Time spent working in prostate cancer care
Respondents declared a range of years working in
prostate cancer care. A total of 158 (55%) had worked
in the field for more than 10 years. Only 32 (11%) had
worked in the field for less than 3 years.
The majority of posts were full time (n=189, 66%),
however the range of time spent working with prostate
cancer patients was variable. Only 23 posts spent
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Table 1 Whole time equivalent (WTE) by geographical distribution
Network Benign
Chemo/day
care Continence
Research/
clinical trials
Surgery
(including
day surgery)
Uro-oncology
(including prostate,
bladder, testicular etc.) Total
Cheshire and Merseyside 0·8 0·0 0·0 0·0 0·5 1·2 2·5
East Midlands 0·0 0·3 0·0 0·0 0·8 3·0 4·0
East of England 0·2 0·0 0·2 0·6 0·0 16·4 17·4
Greater Manchester, Lancashire and South Cumbria 0·8 0·2 0·3 0·0 0·0 13·2 14·4
London 1·4 0·0 1·2 0·0 0·0 16·3 18·9
Northern England 0·0 0·0 0·3 0·3 0·4 4·0 5·0
South East Coast 0·5 0·7 0·0 0·0 0·0 11·6 12·8
South West Coast 1·1 0·1 0·7 0·4 1·0 13·2 16·6
Thames Valley 0·0 0·0 0·0 0·0 0·0 2·1 2·1
Wessex 0·7 0·0 0·8 0·0 0·5 7·3 9·3
West Midlands 0·4 0·0 0·1 0·0 0·6 7·0 8·1
Yorkshire and the Humber 0·9 0·0 1·0 1·5 0·0 6·7 10·0
North Wales 0·0 0·0 0·0 0·0 0·0 1·0 1·0
South Wales 0·0 0·0 0·1 0·5 0·1 6·8 7·6
Northern Ireland 0·3 0·0 0·0 0·0 0·0 2·0 2·3
NHS Grampian 0·0 0·0 0·0 0·3 0·8 2·3 3·4
NHS Highland 0·0 0·0 0·0 0·0 0·0 0·8 0·8
NHS Orkney 0·0 0·0 0·0 0·0 0·0 0·0 0·0
NHS Shetland 0·0 0·0 0·0 0·0 0·0 0·0 0·0
NHS Tayside 0·3 0·0 0·0 0·0 0·0 0·3 0·6
NHS Western Isles 0·0 0·0 0·0 0·0 0·0 0·0 0·0
NHS Borders 0·0 0·0 0·0 0·0 0·0 0·8 0·8
NHS Dumfries and Galloway 0·0 0·0 0·0 0·0 0·0 0·0 0·0
NHS Fife 0·0 0·0 0·0 0·0 0·0 2·2 2·2
NHS Lothian 0·0 0·0 0·1 0·0 0·0 1·0 1·1
NHS Ayrshire and Arran 0·8 0·0 0·0 0·0 0·0 0·5 1·3
NHS Forth Valley 0·0 0·0 0·0 0·0 0·0 0·0 0·0
NHS Greater Glasgow and Clyde 0·0 0·0 0·1 0·0 0·0 1·3 1·4
NHS Lanarkshire 0·0 0·0 0·0 0·0 0·0 0·5 0·5
Total 8·1 1·3 5·0 3·5 4·7 121·3 144·0
100% of their time caring for men with prostate cancer.
Thirty-five nurses spent less than 30% of their time car-
ing for men with prostate cancer, offering some specific
services such as continence or erectile dysfunction ser-
vices, or because no uro-oncology post was available.
The free text responses also reflected the challenge of
covering multiple services:
I work with benign and cancer patients. Find it
difficult to give the cancer patients the time that
they may need due to the workload balance.
Currently trying to bid for administration hours
and more nursing hours for the benign patients.
From these data it is possible to look at a calculated
whole time equivalent (WTE) delivering prostate can-
cer care by geography. This distribution can be seen in
Table 1.
Workforce intentions and configuration
Just under half (n= 140, 49%) of the 285 respondents
to this question declared an intention to retire or leave
the profession within the next 10 years. Of this group,
58 declared an intention to leave in the next 5 years and
13 within the next year. This will represent a substantial
loss of expertise and talent if succession planning is not
considered. This finding reflects the English national
census which shows an ageing workforce in cancer
nursing with 33% of the specialist nursing workforce
now over the age of 50 (Macmillan Cancer Support,
2014). The respondents declared unfilled or frozen
posts. This equated to 58·3 full time equivalents (FTE)
across the UK. This does not reflect need for posts but
only posts currently unfilled. One respondent cited 3·6
WTE posts unfilled. A total of 254 nurses answered a
question on the role they had immediately before the
specialist role they have now. The largest group (99)
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had a previous role in acute inpatient care. Only 48
had come to a specialist role via a development post,
19% of those who responded but there also appears to
be horizontal (45) and downwards (8) movement. With
only three consultant posts in this speciality (Macmil-
lan Cancer Support, 2014), lateral movement is not
unsurprising.
The lack of a career structure for uro-oncology roles
was a recurrent theme in the qualitative comments.
One respondent noted that lack of specialism at ward
level means recruitment to specialist uro-oncology
posts is ‘a major problem… with no good candidates
to take up the role of Urology Nurse Specialist’. There
was also a sense of isolation for nurses who were work-
ing as the single-handed CNS for urology in a trust.
Workforce reconfiguration was clearly underway in
some trusts with some respondents on a fixed-term
contract, a secondment or a post funded by charity
income with no sense of longevity for the role. Some
identified that this was part of a wider review of CNS
posts, with one respondent stating that:
For the second time in four years, we have been
told posts will be lost or downgraded.
The shift towards more community-focused care pro-
vision was seen as a threat to hospital-based posts,
rather than as an opportunity for the post-holder to
take on more community specialist care provision. The
move towards more integrated primary and secondary
care trusts in some parts of the UK may be more
encouraging for services such as uro-oncology.
The sense of threat to the role in some trusts was
also evident. One respondent spoke of the need to
ensure I have evidence to demonstrate the benefits of
our role and grading. Several respondents identified
areas of the service they would like to develop such
as ‘services for African Caribbean men with prostate
cancer, or better transition from hospital to home for
men with prostate cancer, but developing these ideas
or applying for additional funding was not seen as
feasible with the current workload.
Caseload and workload
There was a wide variation in the declared caseloads.
Of 285 responses, 38 nurses (13%) declared a
caseload of less than 100 whilst 52 (18%) had a
caseload of greater than 600. The most common
response was those with a caseload of 600 plus. It
is unlikely that a caseload of this size would allow
for proactive case management. Workload carried
by the individual uro-oncology nurses was variable,
particularly in terms of the range of patient problems/
diagnoses covered. Anecdotally mergers within the
NHS had presented specialists with the challenge of
multisite cover respondents were asked how many
hospital sites they covered. A total of 281 nurses
responded to this question. Most nurses (156) cover
one hospital site; however, eight cover more than five
hospital sites.
The free text responses also indicated that merg-
ers in response to financial pressures presented chal-
lenges to multi-site working:
Between a team of three uro-oncology CNSs
who cover all five urological cancer sites we
cross cover each other when a CNS is on
leave which includes cross covering all CNS
nurse-led clinics. Our nurse-led clinics are rarely
cancelled. (CNS, band 7).
Work left undone
Over half of the respondents (n= 163, 57%) declared
that they were unable to provide best practice nursing
interventions (less than 30% of the time) for patients at
one or more points in the cancer journey.
The most frequent interventions not performed were
formal Holistic Needs Assessments (HNA), prescribing
or recommending medication, and meeting information
needs. Both meeting information needs and assessing
needs from a holistic perspective form part of national
cancer policy in England (Department of Health, 2011),
and are also considered best practice in cancer care
across the rest of the UK.
Qualitative data showed that workload was deemed
to have an impact on patient care, in particular capacity
to undertake formal HNA:
Holistic Needs Assessments are offered and
patients have to ring/see us for them to be done.
No capacity for us to initiate contact. (CNS,
band 6)
Capacity means I do not have opportunity/time
to complete HNA. (CNS, band 7)
HNA not done formally; assessment of needs
done routinely. (CNS, band 8b)
The burden of administration
The data shows that about 68% of the respondents
who have more than 20 h of administrative support
per week work the lowest amount of overtime (sum
28/11+ 8=68%). About 65% of respondents said they
had no administrative support per week or support
for clinic letters only. Of these responses, about 86%
declared that they work overtime with about 36%
6 © 2015 John Wiley & Sons Ltd. and BAUN
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Figure 5 Unpaid overtime and access to administrative support.
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Figure 6 Mean interventions left undone per whole time equivalent (WTE).
declaring that they work at least 4 h overtime per week.
Having administrative support is associated with lower
rates of unpaid overtime (Figure 5). Higher caseloads
were associated with a higher mean declared with nec-
essary interventions left undone (Figure 6).
Education and development
The current workforce is highly educated with many
nurses holding post-registration qualifications, the
highest level of qualification the nurses declared. A
small number of respondents (n= 14, 4·9%) did not
answer this question. Thirty-four respondents said
they have a masters qualification in nursing, the level
recommended in most of the advanced practice frame-
works as the standard of education required to fulfil a
specialist role.
There was a desire for further education and devel-
opment activities across the population with 729 items
chosen by respondents. The highest demand (179)
was for specialist update study days, clinical skills
study days (93), advanced practice courses (81) and
clinical short courses. Qualitative data indicated that
a number of nurses use their own resources (time
and money) for Continuing Professional Development
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(CPD), whilst others rely on charity funding (examples
given: Macmillan Cancer Support and Prostate Cancer
UK). For some nurses, lack of local CPD means that
personal development has to be undertaken online.
All education is in my own time. (CNS, band 7)
Workload precludes taking much time off for
study. (CNS, band 8a)
Current degree education is self-funded in own
time. (CNS, band 7)
CONCLUSIONS OR POSITION
STATEMENT, IMPLICATIONS FOR
PRACTICE
The workforce in this specialism is providing complex
care but has appeared to evolve without strategic intent
and consequently there is a duality to the role for
many-caring for patients with a range of diseases.
As prostate cancer is predicted to become the most
common cancer overall by 2030, consideration of
strategic planning should be given to patterns of care
delivery and the future workforce. Capacity to provide
cancer nursing care needs to be addressed nationally
and locally.
Despite the known benefits of access to a spe-
cialist nurse, the distribution of specialist nurses and
incidence-to-nurse ratios vary enormously indicating
that there is likely to be inequity of access. In addi-
tion, uro-oncology nurses have the highest mean new
patient/incidence (159 per WTE) and 2 year prevalence
(247 per WTE) of specialist nurses in England (Macmil-
lan Cancer Support, 2014). This work indicates that
unlike other cancers, prostate cancer nursing care is
rarely provided by a prostate CNS. This is corroborated
by the national cancer nursing census which shows
that only 2% of the specialist nursing workforce in
WHATIS KNOWN ABOUTTHIS TOPIC
• Prostate cancer is the most common cancer in men in the UK accounting for 25% of all new cases of cancer. It is predicted to become
the most common cancer overall by 2030.
• The value of specialist nurses in cancer is well documented but there was not detailed intelligence on this workforce.
WHATTHIS PAPER ADDS
• This paper is the result of a national survey. The work of specialist nurses caring for men with prostate cancer is clinically complex and
appears to cover most key times in the cancer journey. However, workload appears to be limiting the care that the nurses are able to
provide with over half the respondents (163) saying that they left work undone for patients.
• The workforce appears to ageing and in decline with limited opportunities for succession planning and career progression. This should
be addressed in light of the predicted rise in men with prostate cancer.
England is prostate specific – approximately the same
number as a rare cancer such as sarcoma (Macmillan
Cancer Support, 2014).
From a workforce perspective, retention of staff
in specialist areas is a key concern. Autonomy and
empowerment have been identified as key ‘magnet fac-
tors’ in attracting and keeping high quality staff (Arm-
strong and Laschinger, 2006). The examples of CNS
activity provided above indicate that nurse specialists
in some areas are able to exercise these attributes;
however, there appears to be a deficit of talent man-
agement or provision for succession planning making
this a workforce in decline.
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